ProCE Banner Activity

ExpressPoints
Caring for Patients With Hemophilia A in the Midst of a Therapeutic Revolution

Slideset Download
Download this summary slideset from a live webinar for expert guidance on optimizing factor replacement therapy, incorporating nonfactor therapy, and addressing adherence and comorbidities to improve clinical outcomes for patients with hemophilia A.

Released: December 21, 2021

Begin Activity

Share

Faculty

Miguel A. Escobar

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Department of Hematology
University of Texas Health Science Center
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

Mark Reding

Mark Reding, MD

Professor of Medicine
Division of Hematology, Oncology and Transplantation
Director, Center for Bleeding and Clotting Disorders
University of Minnesota
Minneapolis, Minnesota

Guy A. Young

Guy A. Young, MD

Professor of Pediatrics
Director,
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Sanofi Genzyme

Takeda Pharma USA Inc Takeda Onc Co

Program Director Disclosure

Program Director

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Department of Hematology
University of Texas Health Science Center
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

Faculty Disclosure

Primary Author

Mark Reding, MD

Professor of Medicine
Division of Hematology, Oncology and Transplantation
Director, Center for Bleeding and Clotting Disorders
University of Minnesota
Minneapolis, Minnesota

Guy A. Young, MD

Professor of Pediatrics
Director,
Hemostasis and Thrombosis Center
Childrens Hospital Los Angeles
University of Southern California Keck School of Medicine
Los Angeles, California